Amit Arbune, M.D.

Biography

Amit Arbune, M.D., M.H.A., is an Assistant Professor in the Department of Internal Medicine at UT Southwestern and a member of its Division of Cardiology. He serves as Medical Director for the Cardio-Oncology Clinic at Parkland Health. He also leads the cardio-oncology section for the Global Cancer Consortium and co-directs its certification training, which aims to train cardiologists, hematologists and oncologists, internists, advanced practice providers, and clinical pharmacists in the field of cardio-oncology.

Dr. Arbune received his medical education at Mahatma Gandhi Mission's Medical College in India. He completed internal medicine residency training at North East Ohio Medical University in Youngstown, Ohio, followed by fellowship training in cardiovascular disease at Case Western Reserve University in Cleveland, Ohio, and in advanced cardiovascular imaging at Yale University in New Haven, Connecticut. He also holds a master's degree in healthcare administration from the University of Kentucky in Lexington.

Prior to joining the UT Southwestern faculty in 2025, he was on the faculty at the University of Kentucky, where he served as the Department of Medicine's Quality and Patient Safety Officer and Founding Director of its Cardio-Oncology program, the only program in the state to be recognized by the International Cardio-Oncology Society's as a Gold Level Center of Excellence.

Dr. Arbune studies how cancer treatments can affect the heart and how doctors can find and manage these problems early. He focuses on heart damage caused by medicines like immune checkpoint inhibitors, anthracyclines, and 5‑fluorouracil. He also looks at difficult cases where cancer treatments lead to issues such as abnormal heart rhythms, problems with the heart’s lining, or heart failure. To understand these conditions, he uses advanced heart‑imaging tools like MRI, CT scans, PET scans, and special techniques that measure how well the heart muscle moves. His work also includes finding imaging clues that might predict outcomes for breast cancer patients and improving how hospitals set up services that care for both the heart and cancer needs. Overall, his research aims to help doctors diagnose heart problems from cancer treatments more accurately, identify which patients are at higher risk, and improve the way these patients are cared for.